{"id":"mupirocin-chlorhexidin","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin irritation"},{"rate":null,"effect":"Contact dermatitis"},{"rate":null,"effect":"Burning or stinging at application site"}]},"_chembl":{"chemblId":"CHEMBL3989715","moleculeType":"Small molecule","molecularWeight":"1075.35"},"_dailymed":{"setId":"a83a55e8-58df-ac57-e053-2a95a90a9425","title":"NUSURGEPAK SURGICAL PREP/CAREPAK (CHLORHEXIDINE GLUCONATE, MUPIROCIN, DIMETHICONE) KIT [NUCARE PHARMACEUTICALS INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mupirocin is a topical antibiotic that inhibits isoleucyl-tRNA synthetase, preventing bacterial protein synthesis. Chlorhexidine is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins. Together, they provide synergistic antimicrobial coverage against gram-positive and gram-negative bacteria, commonly used in wound care and infection prevention.","oneSentence":"Mupirocin inhibits bacterial protein synthesis while chlorhexidine disrupts bacterial cell membranes, providing broad-spectrum antimicrobial activity.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:56:09.140Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Wound care and infection prevention"},{"name":"Skin and soft tissue infections"},{"name":"Catheter site care and antisepsis"}]},"trialDetails":[{"nctId":"NCT06397781","phase":"PHASE4","title":"Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2031-01-01","conditions":"Atopic Dermatitis","enrollment":100},{"nctId":"NCT02572791","phase":"PHASE4","title":"Staph Household Intervention for Eradication (SHINE)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-10","conditions":"Skin and Subcutaneous Tissue Bacterial Infections, Staphylococcus Aureus, MRSA - Methicillin Resistant Staphylococcus Aureus Infection","enrollment":835},{"nctId":"NCT03489629","phase":"PHASE2","title":"STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-04-03","conditions":"Cystic Fibrosis","enrollment":37},{"nctId":"NCT06712433","phase":"PHASE2","title":"Bacterial Decolonization Plus Intraoperative Angiography for Soft Tissue Sarcomas Receiving Preoperative Radiotherapy (CONCERTO)","status":"NOT_YET_RECRUITING","sponsor":"Adam Olson","startDate":"2026-09-30","conditions":"Sarcoma,Soft Tissue","enrollment":31},{"nctId":"NCT06378359","phase":"","title":"Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-01-29","conditions":"Staphylococcus Aureus Colonization, Surgical Site Infections, Healthcare Associated Infections","enrollment":250},{"nctId":"NCT06210594","phase":"PHASE4","title":"Staph Intervention for Effective Local Defense","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2024-04-01","conditions":"Staphylococcus Aureus Infection","enrollment":78},{"nctId":"NCT06541145","phase":"NA","title":"Bacterial Decolonization Within Dyads","status":"RECRUITING","sponsor":"Duke University","startDate":"2024-08-21","conditions":"Bacterial Colonization","enrollment":20},{"nctId":"NCT07142408","phase":"PHASE3","title":"The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal","status":"RECRUITING","sponsor":"The Cooper Health System","startDate":"2023-03-13","conditions":"Surgical Wound Infection","enrollment":848},{"nctId":"NCT05586776","phase":"PHASE4","title":"Decolonization to Reduce After-Surgery Events of Surgical Site Infection","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-01-17","conditions":"Surgical Site Infection","enrollment":2700},{"nctId":"NCT06633588","phase":"PHASE4","title":"Decolonization Efficacy of Polyhexanide vs. Mupirocin","status":"RECRUITING","sponsor":"Swiss Paraplegic Research, Nottwil","startDate":"2025-05-01","conditions":"Staphylococcus Aureus, Colonization, Asymptomatic","enrollment":24},{"nctId":"NCT03140423","phase":"PHASE4","title":"Mupirocin-Iodophor ICU Decolonization Swap Out Trial","status":"COMPLETED","sponsor":"Harvard Pilgrim Health Care","startDate":"2017-05-01","conditions":"Staphylococcus Aureus","enrollment":353323},{"nctId":"NCT00532324","phase":"NA","title":"A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA","status":"COMPLETED","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2008-02","conditions":"Staphylococcus Aureus","enrollment":107},{"nctId":"NCT00560599","phase":"PHASE3","title":"A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection","status":"COMPLETED","sponsor":"loren g miller","startDate":"2007-04","conditions":"Methicillin Resistant Staphylococcus Aureus Skin Infections","enrollment":350},{"nctId":"NCT02945722","phase":"PHASE4","title":"Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2018-02-23","conditions":"Hemodialysis Patients","enrollment":434},{"nctId":"NCT05505214","phase":"PHASE2","title":"Topical Steroids & Bacterial Decolonization for Radiation Dermatitis","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2023-09-01","conditions":"Radiation Dermatitis","enrollment":""},{"nctId":"NCT03883828","phase":"PHASE2, PHASE3","title":"Bacterial Decolonization to Prevent Radiation Dermatitis","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2019-06-03","conditions":"Radiation Dermatitis","enrollment":80},{"nctId":"NCT04218799","phase":"PHASE4","title":"Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2014-08-12","conditions":"Human Microbiome","enrollment":19},{"nctId":"NCT04285697","phase":"NA","title":"Infection Prevention Bundle in Brain Tumor Surgery","status":"SUSPENDED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2020-02-20","conditions":"Surgical Site Infection, Brain Tumor","enrollment":300},{"nctId":"NCT03173053","phase":"NA","title":"S. Aureus Decolonization in HPN Patients.","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2018-02-08","conditions":"Staphylococcus Aureus, Motility Disorder","enrollment":63},{"nctId":"NCT02223520","phase":"NA","title":"Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-11","conditions":"Staph Aureus Colonization, Staph Aureus Infection","enrollment":307},{"nctId":"NCT02216227","phase":"NA","title":"Checklist to Prevent MRSA Surgical Site Infections","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2014-04-01","conditions":"Surgical Site Infection","enrollment":1794},{"nctId":"NCT03962907","phase":"PHASE4","title":"Preoperative Decolonization and Surgical Site Infections in Orthopaedic Surgery - 2 Year Outcome in Prosthetic Surgery","status":"COMPLETED","sponsor":"Lindenhofgruppe AG","startDate":"2019-01-01","conditions":"Staphylococcus Aureus, Orthopaedic Surgery, Surgical Site Infection","enrollment":1318},{"nctId":"NCT04222699","phase":"PHASE4","title":"Cultures Before and After Decolonization in Community Dwelling Adults With Current S. Aureus Colonization","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2012-09-18","conditions":"Human Microbiome","enrollment":58},{"nctId":"NCT01138462","phase":"NA","title":"Control of MRSA in Nursing Homes: Decolonization vs Standard Precautions","status":"COMPLETED","sponsor":"University of Lausanne Hospitals","startDate":"2010-06","conditions":"Methicillin-Resistant Staphylococcus Aureus","enrollment":157},{"nctId":"NCT01438515","phase":"NA","title":"Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization","status":"COMPLETED","sponsor":"Horizon Health Network","startDate":"2008-08","conditions":"Methicillin-resistant Staphylococcus Aureus","enrollment":100},{"nctId":"NCT02182115","phase":"PHASE4","title":"S. Aureus Screening and Decolonization","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2014-07","conditions":"Wound Infection Due to Staphylococcus Aureus, MRSA Infection of Postoperative Wound","enrollment":110},{"nctId":"NCT01302210","phase":"","title":"Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities","status":"COMPLETED","sponsor":"Endeavor Health","startDate":"2010-10","conditions":"Methicillin Resistant Staphylococcus Aureus","enrollment":22302},{"nctId":"NCT02547103","phase":"PHASE4","title":"Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection","status":"UNKNOWN","sponsor":"Chiang Mai University","startDate":"2016-06-01","conditions":"End Stage Renal Disease, Peritoneal Dialysis","enrollment":354},{"nctId":"NCT02063867","phase":"NA","title":"Active Bathing to Eliminate Infection (ABATE Infection) Trial","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2014-04","conditions":"Healthcare Associated Infections, Methicillin Resistant Staphylococcus Aureus, Multi Drug Resistant Organisms","enrollment":53},{"nctId":"NCT00966446","phase":"NA","title":"Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-09","conditions":"MRSA - Methicillin Resistant Staphylococcus Aureus Infection","enrollment":223},{"nctId":"NCT01594827","phase":"PHASE2","title":"Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Cystic Fibrosis","enrollment":29},{"nctId":"NCT02029872","phase":"PHASE4","title":"Stop Community MRSA Colonization Among Patients","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-01","conditions":"MRSA","enrollment":77},{"nctId":"NCT02560155","phase":"NA","title":"Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial","status":"COMPLETED","sponsor":"Lindenhofgruppe AG","startDate":"2015-11","conditions":"Orthopedic Disorders, Surgical Site Infection","enrollment":1300},{"nctId":"NCT02566928","phase":"PHASE4","title":"Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence","status":"UNKNOWN","sponsor":"Clinical Directors Network","startDate":"2015-10","conditions":"Methicillin-Resistant Staphylococcus Aureus, Recurrence, Staphylococcal Skin Infections","enrollment":278},{"nctId":"NCT03081962","phase":"PHASE3","title":"Effect of a Combination of Bundles on Surgical-site Infection After Elective Colorectal Surgery","status":"UNKNOWN","sponsor":"Hospital General Universitario Elche","startDate":"2017-02-15","conditions":"Surgical Site Infection","enrollment":102},{"nctId":"NCT01349192","phase":"PHASE2","title":"Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2011-04","conditions":"Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus","enrollment":47},{"nctId":"NCT00980980","phase":"NA","title":"Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)","status":"COMPLETED","sponsor":"Harvard Pilgrim Health Care","startDate":"2009-09","conditions":"Methicillin-resistant Staphylococcus Aureus","enrollment":74256},{"nctId":"NCT01537783","phase":"PHASE4","title":"Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2011-09","conditions":"Cutaneous Abscess","enrollment":50},{"nctId":"NCT00513799","phase":"NA","title":"The Natural History of Community-Associated MRSA Infections and Decolonization Strategies","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2007-03","conditions":"Abscesses, Furunculosis, Staphylococcus Aureus","enrollment":300},{"nctId":"NCT01820455","phase":"NA","title":"MRSA in a Trauma Population: Does Decolonization Prevent Infection?","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2012-01","conditions":"MRSA Colonization","enrollment":55},{"nctId":"NCT01918813","phase":"NA","title":"Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening","status":"COMPLETED","sponsor":"Chikara Tashiro","startDate":"2009-11","conditions":"Inflammatory Bowel Disease, Hepatobiliary Disease, Pancreas Disease","enrollment":662},{"nctId":"NCT01400308","phase":"PHASE4","title":"Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA)","status":"TERMINATED","sponsor":"B. Braun Medical SA","startDate":"2010-02","conditions":"MRSA - Methicillin Resistant Staphylococcus Aureus Infection, MRSA Colonization","enrollment":99},{"nctId":"NCT01232231","phase":"NA","title":"Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting","status":"COMPLETED","sponsor":"Joseph Kim","startDate":"2010-07","conditions":"Methicillin-resistant Staphylococcus Aureus","enrollment":15},{"nctId":"NCT00731783","phase":"NA","title":"Staphylococcus Aureus Decolonization Study","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2008-07","conditions":"Staphylococcal Skin Infections, Abscesses, Furunculosis","enrollment":183}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Mupirocin + Chlorhexidin","genericName":"Mupirocin + Chlorhexidin","companyName":"B. Braun Medical SA","companyId":"b-braun-medical-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mupirocin is a small molecule inhibitor of isoleucyl-tRNA synthetase, classified as an INHIBITOR drug class. It is used to treat Staphylococcus Aureus, Methicillin-Resistant Staphylococcus Aureus, and Staphylococcal Skin Infections, among other conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}